MedPath

Shenzhen Turier Biotech Co., Ltd.

Shenzhen Turier Biotech Co., Ltd. logo
🇨🇳China
Ownership
Holding
Established
2016-04-18
Employees
-
Market Cap
-
Website
http://www.turierbiotech.com

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of TB001 in Healthy Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2022-04-04
Last Posted Date
2023-04-13
Lead Sponsor
Shenzhen Turier Biotech Co., Ltd
Target Recruit Count
64
Registration Number
NCT05308940
Locations
🇨🇳

Shenzhen Turier Biotech Co., Ltd., Shenzhen, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath